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Abstract—This article describes the creation of an agent-based
model of blood coagulation within the Lindsay Composer (LC)
computational framework, which can be used to simulate and
visualize physiological processes inside the human body. Swarm
Graph Grammars (SGG), a generic modelling language, are
used to design the interaction behaviours of the involved bio-
agents which represent the cellular and chemical structures
found in human blood. Physical interactions among the agents,
such as collisions and binding, are computed by an embedded
physics engine. In order to effectively retrace and to accurately
model coagulation, comparisons with the results of established
mathematical models are drawn. The blood coagulation simu-
lation accounts for the formation, expression, and propagation
of blood clots within the injured area of a blood vessel. We
demonstrate how 3-dimensional, interactive agent-based models
and programming frameworks provide complementary tools for
research, for learning and for exploring the complicated nature
of physiological processes.
Keywords: Agent-based Simulation, Blood Coagulation,
Swarm Graph Grammars, Lindsay Composer
I. INTRODUCTION
THE human circulatory system is responsible for transport-ing materials (such as nutrients, hormones, and immune
cells) within the entire body [1]. One of the important aspects
of this system is its coordination with the homeostatic system
to limit the loss of blood after an injury. The natural process
of stopping the flow and loss of blood, occurs in three stages:
(a) vascular spasm, or intense contraction of blood vessels in
the area of the injury, (b) formation of a platelet plug, and
(c) blood clotting. Once blood loss has stopped, the tissue
healing process begins [1]. Understanding the biological and
physiological processes of blood coagulation is important for
applications in the biomedical sciences. For instance, there
are many disorders, which can be resolved given that the
blood coagulation process is well understood, such as improper
regulation of thrombus growth, thrombotic complication with
cancer, or vessel blocking effects of clots [2].
Computational and mathematical models can be used as one
of the available tools for grasping the complexities of biolog-
ical processes. There have been numerous studies to simulate
the blood coagulation process computationally. However, this
process is an extremely complicated homeostatic mechanism,
which involves various biochemical and mechanical factors.
Therefore, most of these attempts are focused on specific
aspects of the entire system. For instance, there are only a
few models that couple the formation of the platelet plug with
the formation of the clot. Almost all of these studies rely on
ordinary differential equations (ODEs) or partial differential
equations (PDEs) to model the process [2]. These studies
generally lack stochasticity, which is greatly important for
biological systems. Furthermore, these mathematical models
are not able to propose an easy way to demonstrate accurate
3D visualizations and interactivity. Blood coagulation, as well
as other biological processes can be computationally modelled
using an agent-based modelling (ABM) paradigm. ABMs de-
scribe the interactions between autonomous, decision-making
entities called agents [3]. As a whole, the local interactions
between these agents may result in a system-wide change. In
fact, systems that are modelled using this paradigm can be
highly sensitive to small details, such as specific local agent
interactions or the order of execution of the agents.
Swarm graph grammars (SGGs) provide a unified algorith-
mic language for developing such agent-based models. The
SGG modelling language is able to address the complexity of
biological systems across different scales [4]. A SGG describes
agent behaviours by a set of rules. Each rule consists of a set
of predicates and a set of actions. At each step in a simulation,
the predicate set of a rule is tested, and if it is true, its action
set is executed. Thus, a simulation is driven by the sequential
executions of if-then rules.
The blood coagulation simulation is developed within a
computational framework called the Lindsay Composer (LC)
that contains various embedded computational engines such as
the Swarm Graph Grammar Engine. This framework utilizes
efficient embedded computational engines with visualization
technologies and is considered an ideal simulation environ-
ment for developing visual and complex biological and phys-
iological models. Based on the materials discussed above, the
goals of this project are: (1) Developing an accurate computa-
tional simulation to study the blood coagulation process, and
(2) providing a semi-realistic 3D visualization and an intuitive
way for composing, computing and demonstrating different
model scenarios.
The remainder of this article is organized as follows. In
section 2, we review related work with respect to the blood
coagulation process. Section 3 presents the biological details
of blood coagulation as well as the bio-agents that can be
identified. Section 4 describes our model and its methodology.
Section 5 is dedicated to the computational framework used
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in this study, and in Section 6 the results of the simulation are
presented. Section 7 draws the conclusion for this study.
II. RELATED WORK
Due to the complex nature of coagulation and its serious
clinical consequences, there have been a number of studies
focusing on different perspectives. Over the past 30 years,
a reasonably comprehensive understanding of the processes
involved in blood coagulation has been developed. The fol-
lowing is a brief overview of research conducted in this area
over the last decade.
The kinetics of the extrinsic and intrinsic pathways and
their feedback loops have been modeled using a PDE system
in a study conducted in 1989 [5]. Later on in 1993 and
1994, this study has been enriched with more details with
closer correlation to experimental results [6], [7]. In 2001, it
was shown that the activation threshold for the coagulation
chemical cascade is affected by the flow rate, size of the
wound site, and the initial concentration of the chemicals
[8]. In 2004, a PDE model was introduced to describe the
interactions between platelets and sub-endothelial layers and
cohesion of activated platelets [9]. A relatively comprehen-
sive model of coagulation was proposed in 2005, in which
rheological properties of the clot, Newtonian fluid models,
biochemical interactions, and fibrogenesis were incorporated.
This study employed convection-reaction-diffusion equations
to model platelet activation, whereas the formation of the clot
is modelled as a sheer thinning viscoelastic region, which first
forms over time and then gradually dissolves [10].
We present two recent studies in some more detail, as they
proved seminal in informing our own work. The first study
is a PDE model of coagulation, which encompasses all the
chemicals that are known to be involved in the process [11].
The second model is a hybrid of PDEs and a Cellular Potts
Model (CPM); it is considered one of the most comprehensive
models of coagulation today [2]. These two studies are not
only used to compare the results obtained in our work, but they
also show how an ABM approach like ours can be considered
a complementary tool and method for the study of complex
biological systems in general.
A. A Model for Stoichiometric Regulation of Blood Coagula-
tion
A PDE system is used to describe the vitamin K-dependent
coagulation process [11]. The coagulation kinetics in this
model contains 27 equations, which describe the fate of 34
chemical species. The final result of this system describes how
the concentration of thrombin at the injury site changes over
the course of the simulation. The concentration of thrombin
varies, based on the initial concentration of tissue factors
released at the wound site. The initial concentration of tissue
factors is a function of the size and characteristics of the
wound site.
Even though there is a relatively close correlation between
the results of this model and in vivo experiments, this model
did not consider the role of platelets in the formation of the
clot. Neither were the physical and hydrodynamical factors
reflected in this study.
B. A Multiscale Model of Thrombus Development
Xu et al. present a two dimensional multi-scale model of
the blood coagulation process [2]. The biochemical structures
used in this model are blood cells, blood plasma, activated
and inactivated platelets, fibrinogen, activating chemicals, and
vessel walls. The multi-scale hierarchy of this model is divided
into three levels: 100 micrometer, 1 micrometer for cellular
structures, and 0.1 micrometer for sub cellular and chemical
structures. The modelling approach used is a hybrid of three
main sub-models: cell sub-model, biochemical reaction sub-
model, and flow sub-model. The cell sub-model is a discrete
stochastic Cellular Potts Model (CPM) that represents different
types of cells such as platelets and blood cells [12]. CPM is
a lattice based computational model, wherein the simulation
environment is divided into many lattice sites represented as
pixels. Each pixel is associated with an index and an energy
state. Pixels that share the same index belong to the same cell.
The behaviours of the cells and their interactions are defined in
terms of effective energies. At each CPM time step, a pixel is
randomly chosen and, based on its energy state, a change of its
index is attempted. When a pixel changes its index, it means
that the pixel is shifted from one type of cell to another. Over
the course of the simulation, the CPM evolves to minimize
the total energy of the simulation [12].
The biochemical reaction sub-model is basically a PDE
system that is used to describe the biochemical nature of
the system. Navier-Stokes equations are used to describe the
hydrodynamics of blood flow. The intention for hybridizing
these modelling paradigms is to capture the discrete aspects
of the coagulation process at the micro-scale level, such as
enzyme threshold effects in cells, as well as its continuous
aspects at the macro-scale level, such as continuous extension
of the clot at the wound site. At each iteration of this
simulation, both equation systems are solved and used for
updating the CPM.
The resulting simulation successfully demonstrates the for-
mation of the clot at the wound site. This model is fairly
comprehensive. However, it does not fully describe some as-
pects of coagulation. For instance, the biophysical complexity
of the system is not well captured, as the physical interactions
are limited to the 2-dimensional environment of the CPM.
Therefore, it is suggested that other modelling approaches
are easier to employ and still more successful in simulating
complex biological systems [13].
III. BIOLOGICAL ASPECTS AND AGENT-BASED MODEL
The coagulation process is initiated after any vascular
damage is sustained, which results in the contact between
blood cells, thrombogenic factors and sub-endothelial proteins
such as collagen. According to the classic view, there are
two ways to initiate the blood coagulation process: via the
intrinsic and extrinsic pathways. The intrinsic pathway is
initiated when blood cells touch the chemicals released from
the damaged membranes of the endothelial and sub-endothelial
cells at the injury site. These activating chemicals are able to
activate the inactivated platelets within the blood flow. The
extrinsic pathway takes place when the chemicals released
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Fig. 1. The interactions between the agents involved in the blood coagulation
process initiated by a trauma message.
from activated platelets meet those that have not been activated
yet [14]. After these two pathways, the coagulation process
enters the common pathway, where the complex structure of
fibril networks is formed. These pathways are complex and
involve many chemical activities. The outcome of this process
is the formation of a clot, which is basically a multi-layer
mesh of platelet plugs covered with fibril networks.
In order to model the blood coagulation process the body
should be considered as a set of multiple swarms. In fact,
the human body is essentially a swarm of swarms, in which
multiple types of swarms interact with each other [3], [15]. In
this study, it is assumed that all the agents involved essentially
behave like swarms. For instance, platelets would be swarm
agents that interact and aggregate together based on a set of
interaction rules. By studying the process of blood coagulation
from a swarm perspective, the interaction between the agents
can be formulated as a set of rules. All the interactions are
local and occur via collisions. There is no central control in
the system directing the agents to form a clot, or even to direct
them toward the wound site. This means that the formation
of the clot is the result of the independent interactions of
individual agents. The strength of this approach is that the
agents interact based on simple rules, which eventually results
in the complex structure of the clot.
Our simulation contains 12 types of agents (Fig. 1). The
main interactions in the simulation are adhesion, activation,
and secretion. For example, in a simple scenario, collagen
proteins at the wound site activate inactivated platelets within
the blood flow. Activated platelets then secrete thrombin,
ADP, and serotonin. The activating chemicals activate other
inactivated platelets in the blood flow. Activated platelets
adhere to each other to form the platelet plug. Any fibrinogen
that comes into contact with thrombin molecules becomes acti-
vated. Activated fibrinogens are called fibrins, which adhere to
each other to form a fibril network. In combination, the platelet
plug and fibril networks form the clot at the wound site. These
interactions are specified in the form of simple rules, which
we formulate as Swarm Graph Grammars as explained in the
following section.
Fig. 2. Algorithm for the SGG engine in Lindsay Composer, which takes
care of the ordered execution of the rules.
IV. METHODOLOGY
Swarm graph grammars (SGGs) are a unified modelling
language for developing complex agent-based systems [4].
The behaviour of an SGG’s agent is described by a set of
rules. Each rule is composed of a set of if-conditions known
as predicates and a set of associated actions. The actions are
executed if and only if the set of all predicates is true. The
application of each rule is associated with a probability. For
instance, if the probability associated with a SGG rule is 0.4,
it means that if the set of predicates of this rule is true, the
probability of execution of the rule’s actions is 0.4 per given
evaluation of that set of rules. The algorithm, which takes care
of the ordered execution of actions in each simulation step,
works through the Lindsay Composer SGG engine as outlined
in Figure 2 [4].
Agents are aware of their neighbors within a specified
distance and can interact with them. As a result of these
interactions, agents may change their directions, velocities,
and states [4]. The state of an agent is associated with its
energy level. Its state may be changed due to a specific rule.
The agent’s characteristics and graphical representation are
also influenced by its state. For instance, platelets can have
three different states: inactivated, activated, and deactivated.
The color and rate of activation of a platelet are determined
by its state.
V. THE COMPUTATIONAL FRAMEWORK
Lindsay Composer (LC) is a 3-dimensional, component-
based modelling framework, which utilizes various compu-
tational engines and visualization technologies. The objective
of the LC framework is to integrate the computational mod-
els of physiological functions across the human body. Each
object in Lindsay Composer is represented as a hierarchy of
components. Each of these components are handled by one
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Fig. 3. SGG rules of a platelet. Each component is defined by the aggregation
of its child components. For instance, a platelet has a physics, behaviour,
transform, and graphics component. The behaviour component contains the
SGG rules of the agent.
Fig. 4. The graphical user interface to adjust parameters during a simulation.
of the engines of the LC [16]. For instance, if an object has
a rigid body component, its physical interactions with other
physical objects in the simulation context are handled by the
LC physics engine. Dependencies among components, such
as binding the 3D representation of an object to its physical
state, are described through hierarchal relationships between
components. In addition, there is a LC Swarm Graph Grammar
Engine to simulate agent interactions. For instance, when two
or more agents collide, a message is sent to this engine,
which then executes any possible if-then rules between those
agents. Figure 3 demonstrates the hierarchal structure of a
platelet in the Lindsay Composer. Each platelet has a physics,
behaviour, transform, and graphics component. The behaviour
component encompasses the SGG rules of the agent. In the
case of blood clotting, these rules are activation, adhesion,
and secretion. One of the benefits of the framework is that
it provides a number of graphical user interfaces (GUI) that
are used to adjust simulation parameters dynamically. Figure
4 is the GUI for coagulation simulation. Other GUIs enable
users of the system to add or remove agents, or apply new
behaviours to agents within the simulation. These features
make the Lindsay Composer a good framework for developing
an interactive, 3-dimensional blood coagulation simulation
with illustrative visuals that help in the understanding of the
underlying processes.
VI. RESULTS
We used previous experimental and modelling studies to
calibrate our own model, with parameters adopted from [2].
Figure 5 shows different steps of a typical run of our simula-
tion. At the beginning of the simulation, red blood cells and
other blood components are flowing out of the ruptured vessel
(t1). Some platelets are activated and adhere to the wound site
as a result of their interactions with collagen proteins. These
activated platelets secrete activating chemicals such as throm-
bins (shown as blue spheres), which in turn activate fibrinogen
molecules and other inactivated platelets (t2). The simulation
proceeds with the formation of the platelet plug as well as
some fibril networks (shown in white, t3). Finally, the clot is
completely formed and prevents the blood components to drip
out of the vessel (t4). Activated platelets also reached their
deactivated state, with no further thrombogenesis. Continued
generation of thrombin could lead to the condition known as
stasis, where the normal flow of blood stops within the vessel
as the clot blocks its way, which we discuss in more detail in
subsection 6.2.
A. Normal Blood Coagulation
Figure 6 shows the graphs plotted for a typical blood coag-
ulation experiment. Graph 1 compares the number of activated
(cyan) and inactivated (green) platelets. At the beginning of
the simulation, the number of activated platelets increases
rapidly. Over time, the rate of platelet activation decreases
until there is no more platelet activation by the end of the
simulation. This activation trend closely correlates with the
results presented in [17]. Graph 2 shows the number of fibrins
(dark blue) and number of fibrinogens (purple). Graph 3 plots
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Fig. 5. The blood coagulation simulation at different time steps (t1 ¡ t2 ¡
t3 ¡ t4 ). The process is observed from two different perspectives: inside and
outside of the vessel.
changes in the number of thrombin molecules (green) and
the number of all the activating chemicals together (blue).
As greater numbers of platelets get activated, the number of
activating chemicals also increases. However, as the simulation
proceeds more activated platelets reach their deactivated state.
Consequently, the number of activating chemicals drops to
zero. The trend observed for changes in the concentrations of
activating chemicals is similar to the trends presented in [11].
Graph 4 compares the number of platelets that are activated
by collagen proteins at the wound site (red) with the number
of platelets that are activated by activating chemicals (blue).
At the beginning of the simulation, clot formation is initiated
by collagen proteins that are exposed to the bloodstream after
the injury. However, as the wound is filled by platelet plugs
Fig. 6. Agent counts in the case of normal coagulation. (a) activated platelets
(cyan) and inactivated platelets (lime green), (b) fibrinogens (purple) and
fibrins (dark blue), (c) all the activating chemicals (azure blue) and changes
in the number of thrombins (green), (d) collagen proteins in activation of
platelets (red) and activating chemicals in activating platelets (blue).
Fig. 7. Agent counts in the case of abnormal coagulation (thrombosis). (a)
activated platelets (cyan) and inactivated platelets (lime green), (b) fibrinogens
(purple) and fibrins (dark blue), (c) all the activating chemicals (azure blue)
and changes in the number of thrombins (green), (d) collagen proteins in
activation of platelets (red) and activating chemicals in activating platelets
(blue).
and as there is no more room left for further interactions
between flowing platelets and collagen proteins, the activating
chemicals play a major role for the activation of other platelets.
B. Thrombosis
The presented model can also be used to study pathologic
cases such as thrombosis, which results in the pathological
development of a clot. There are many causes for this disorder,
with one being overreaction of coagulation response. The
response may be observed as an increase in the number of
platelets in the bloodstream. Figure 7 shows a simulation in
which the number of platelets in the bloodstream is 1.5 times
more than normal, with their secretion rate increased by 25
percent. The simulation time is exactly the same as in the
normal case.
The expansion of the clot (thrombogenesis) is not regulated
properly and the clot occupies the cross section of the ves-
sel and blocks the blood flow. Figure 7 shows the graphs
plotted for this experiment. The number of activated platelets
constantly increases (Graph 1, cyan line), which leads to
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Fig. 8. Clot structure in an abnormal case (thrombosis). The clot blocks
the blood flow, which means the vessel is no longer functional for the
transportation of blood.
the oversecretion of activating chemicals (Graph 4, blue line
and both lines in Graph 3). The oversecretion of activating
chemicals leads to the formation of increased number of
fibrin molecules as well (Graph 2, blue line). As a result,
thrombogenesis is not stopped appropriately and blocks the
blood components (such as red and white blood cells) to flow
through the vessel (Fig. 8).
VII. CONCLUSION
We have presented a 3-dimensional, interactive, agent-based
model of the blood coagulation process. Simulation accounts
for biologically validated agent-based interactions, as well as
a semi-realistic visualization of the process. Users are able to
manipulate the parameters and observe their effects on the
simulation in real time. This simulation is rendered in an
interactive 3D environment and can be observed from different
camera perspectives. The result of this study has the potential
to be used as a tool for both educational exploration and
research.
REFERENCES
[1] Human Biology: Concepts and Current Issues. Pearson, 2006.
[2] Z. Xu, N. Chen, M. M. Kamocka, E. D. Rosen, and M. Alber, “A
multiscale model of thrombus development,” Journal of The Royal
Society Interface, vol. 5, no. 24, pp. 705–722, 2008. [Online]. Available:
http://rsif.royalsocietypublishing.org/content/5/24/705.abstract
[3] C. Jacob and I. Burleigh, “Biomolecular swarms - an agent-
based model of the lactose operon,” Natural Computing, vol. 3,
pp. 361–376, 2004, 10.1007/s11047-004-2638-7. [Online]. Available:
http://dx.doi.org/10.1007/s11047-004-2638-7
[4] S. von Mammen, D. Phillips, T. Davison, and C. Jacob, “A graph-based
developmental swarm representation and algorithm,” in Swarm Intelli-
gence, ser. Lecture Notes in Computer Science, M. Dorigo, M. Birattari,
G. Di Caro, R. Doursat, A. Engelbrecht, D. Floreano, L. Gambardella,
R. Groß, E. Sahin, H. Sayama, and T. Stu¨tzle, Eds. Springer Berlin /
Heidelberg, 2010, vol. 6234, pp. 1–12.
[5] M. Khanin and V. Semenov, “A mathematical model of the
kinetics of blood coagulation,” Journal of Theoretical Biology,
vol. 136, no. 2, pp. 127 – 134, 1989. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S0022519389802206
[6] J. Jesty, E. Beltrami, and G. Willems, “Mathematical analysis of a
proteolytic positive-feedback loop: Dependence of lag time and enzyme
yields on the initial conditions and kinetic parameters,” Biochemistry,
vol. 32, no. 24, pp. 6266–6274, 1993, pMID: 8512937. [Online].
Available: http://pubs.acs.org/doi/abs/10.1021/bi00075a021
[7] S. Baldwin and D. Basmadjian, “A mathematical model of thrombin
production in blood coagulation, part i: The sparsely covered
membrane case,” Annals of Biomedical Engineering, vol. 22,
pp. 357–370, 1994, 10.1007/BF02368242. [Online]. Available:
http://dx.doi.org/10.1007/BF02368242
[8] E. Beltrami and J. Jesty, “The role of membrane patch size
and flow in regulating a proteolytic feedback threshold on a
membrane: possible application in blood coagulation,” Mathematical
Biosciences, vol. 172, no. 1, pp. 1 – 13, 2001. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S0025556401000645
[9] A. L. Fogelson and R. D. Guy, “Platelet–wall interactions
in continuum models of platelet thrombosis: formulation
and numerical solution,” Mathematical Medicine and Biology,
vol. 21, no. 4, pp. 293–334, 2004. [Online]. Available:
http://imammb.oxfordjournals.org/content/21/4/293.abstract
[10] M. Anand, K. Rajagopal, and K. Rajagopal, “A model for the
formation and lysis of blood clots.” Pathophysiology of haemostasis
and thrombosis, vol. 34, no. 2-3, 2005. [Online]. Available:
http://ukpmc.ac.uk/abstract/MED/16432312
[11] M. F. Hockin, K. C. Jones, S. J. Everse, and K. G. Mann, “A
model for the stoichiometric regulation of blood coagulation,” Journal
of Biological Chemistry, vol. 277, no. 21, pp. 18 322–18 333, 2002.
[Online]. Available: http://www.jbc.org/content/277/21/18322.abstract
[12] N. Chen, J. A. Glazier, J. A. Izaguirre, and M. S. Alber, “A
parallel implementation of the cellular potts model for simulation
of cell-based morphogenesis,” Computer Physics Communications,
vol. 176, no. 11-12, pp. 670 – 681, 2007. [Online]. Available:
http://www.sciencedirect.com/science/article/pii/S0010465507002044
[13] S. von Mammen, T. Davison, A. Sarraf, V. Sarpe, I. Yazdanbod, and
C. Jacob, “Swarm intelligence for everyone, accessible modelling and
simulation of complex biological systems,” University of Calgary, Tech.
Rep., 2010.
[14] Medical Physiology. Elsevier Saunders Inc, 2005.
[15] The swarming body, 1994.
[16] S. von Mammen, T. Davison, H. Baghi, and C. Jacob, “Component-
based networking for simulations in medical education,” Computers and
Communications, IEEE Symposium on, vol. 0, pp. 975–979, 2010.
[17] E. N. Sorensen, G. W. Burgreen, W. R. Wagner, and J. F. Antaki,
“Computational simulation of platelet deposition and activation: I.
model development and properties,” Annals of Biomedical Engineering,
vol. 27, pp. 436–448, 1999, 10.1114/1.200. [Online]. Available:
http://dx.doi.org/10.1114/1.200
